Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹482 Cr₹457 Cr₹489 Cr₹90 Cr₹94 Cr

What is the latest Total Non-Current Liabilities ratio of GLAND PHARMA ?

The latest Total Non-Current Liabilities ratio of GLAND PHARMA is ₹482 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹482 Cr
Mar2025₹457 Cr
Mar2024₹489 Cr
Mar2023₹90 Cr
Mar2022₹94 Cr

How is Total Non-Current Liabilities of GLAND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹482 Cr
5.45
Mar2025 ₹457 Cr
-6.41
Mar2024 ₹489 Cr
444.83
Mar2023 ₹90 Cr
-4.57
Mar2022 ₹94 Cr -

Compare Total Non-Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,865.6 Cr 1.3% 2.2% 47.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.3%

2.2%

47.8%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses